Rocket Lab SEC Filings

Nina Armagno, a Director at Rocket Lab USA, Inc., was granted 81,943 restricted stock units (RSUs) on October 30, 2023, under the company's Non-Employee Director Compensation Policy. The RSUs vest one-third annually over three years. This acquisition is a moderately bullish signal, aligning director interests with shareholders.

Rocket Lab's 41st Electron mission on September 19, 2023, succeeded in first stage burn and separation but experienced an anomaly at T+2:30, terminating the mission. The company is leading an anomaly investigation with FAA oversight, postponing the next mission originally scheduled before Q3 end. Press releases issued on launch results and Q3 2023 guidance update; no quantifiable financial impact disclosed.

This SC 13D/A amendment discloses Equatorial Trust, linked to Rocket Lab CEO Peter Beck, sold 3,600,000 common shares on September 11, 2023, via block trade with Goldman Sachs at $5.62 per share. Post-sale beneficial ownership is 50,951,250 shares (10.5%). Beck orally agreed not to sell additional shares in 2023.

Edward H. Frank, Director at Rocket Lab USA, Inc., acquired 16,656 restricted stock units (RSUs) on September 12, 2023, at $0.00 per share under the Non-Employee Director Compensation Policy. Post-transaction, he directly owns 123,691 shares. This routine compensation grant sends a neutral insider signal.

Peter Beck, President, CEO, and Chairman of Rocket Lab USA, indirectly sold 3,600,000 shares of common stock at $5.62 per share through the Equatorial Trust (family trust) on September 11, 2023. Post-sale, the trust holds 50,951,250 shares. This large discretionary sale signals moderate bearish sentiment.

Form 144 discloses Rocket Lab CEO Peter Beck's intent to sell 3,600,000 common shares acquired in the 2021 merger. Shares valued at $22.32 million (~$6.20/share) to be sold via Goldman Sachs on 09/11/2023. No prior sales in past 3 months; relevant for tracking insider activity.

Michael D. Griffin, Director at Rocket Lab USA, sold 38,090 shares of common stock on 08/30/2023 at $6.3432 weighted average through LogiQ, Inc., reducing indirect holdings to zero while retaining 39,446 direct shares. This discretionary sale (no 10b5-1 plan) is moderately bearish, indicating potential liquidity needs or reduced confidence.

This Form 144 discloses Director Michael D. Griffin's intent to sell 38,090 common shares of Rocket Lab USA, Inc. on or around 08/30/2023, acquired via restricted stock vesting on 06/14/2023 as compensation, with aggregate market value of $241,614. Griffin sold 50,689 shares on 06/06/2023; the filing certifies no undisclosed material adverse information.

Arjun Kampani, Senior Vice President, General Counsel and Secretary at Rocket Lab USA, sold 20,675 shares on 08/25/2023 at a weighted average price of $5.7436. This was a 'sell-to-cover' transaction to satisfy tax obligations on vesting restricted stock units (RSUs). The signal is neutral as it is a routine, non-discretionary tax-related sale.

Adam C. Spice, Chief Financial Officer, sold 61,377 shares of common stock on 08/25/2023 at a weighted average price of $5.7436 through a sell-to-cover transaction to satisfy tax withholding on vesting RSUs. Post-transaction, he holds 1,566,293 shares directly. This routine, non-discretionary sale is neutral.